Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Represents Australian Medical Research Institute in Landmark Royalty Monetization

July 27, 2017

NEW YORK—Covington advised The Walter and Eliza Hall Institute of Medical Research (WEHI), Australia's oldest medical research institute, in its landmark monetization of a portion of its royalties relating to the cancer drug Venetoclax. The purchaser, a wholly owned subsidiary of Canada Pension Plan Investment Board, paid US$250 million upfront, and agreed to make up to US$75 million in additional payments, subject to the attainment of certain milestones. This royalty monetization is believed to be the largest royalty monetization by a non-profit institution outside the United States.

The Covington team consisted of John Gourary, Rachel Beller, and Jennifer Garnett (corporate), Gary Rubman and Morag Peberdy (IP), and Ansgar Simon (tax).

 

Share this article: